Nourshahi, M., Kaviani, M., Kimiagar, M., and Ebrahim, K
After certain GLP-1 receptor agonist drugs such as Ozempic and Wegovy were placed on the FDA drug shortage list, specialized pharmacies began compounding semaglutide and other similar peptide-based drugs for patients seeking to use them for weight loss purposes
By providing your cells with the highly bioavailable, activated cofactors they desperately need, you can begin to support your body's innate ability to generate energy and resolve chronic inflammation
This issue has also been recently reviewed by De Block et
All extended protocols require ongoing medical supervision to ensure continued safety and appropriate therapeutic use